Genzyme Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 11 Forbes Road, Northborough, Massachusetts (MA) 01532, United States (USA)
- Operations here
- analysislabelpackrelabelrepack
- FDA identifiers
- FEI 3009389940 · DUNS 050424395
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-08-14
- VAIBlood and Blood Products2025-02-14
- NAIDrug Quality Assurance2020-02-28
- NAIDrug Quality Assurance2018-07-19
- VAIDrug Quality Assurance2016-08-18
- NAIDrug Quality Assurance2014-09-18
- NAIDrug Quality Assurance2012-02-17
Drugs this plant is listed as making
13 distinct drugs across 26 products name this site in their FDA label.
- Agalsidase BetaGenzyme Corporation
- Alglucosidase AlfaGenzyme Corporation
- Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtlBioverativ Therapeutics Inc.
- avalglucosidase alfa-ngptGenzyme Corporation
- caplacizumabGenzyme Corporation
- DronedaroneSanofi-Aventis U.S. LLC
- fitusiranGenzyme Corporation
- ImigluceraseGenzyme Corporation
- insulin glargineSanofi-Aventis U.S. LLC
- olipudase alfa-rpcpGenzyme Corporation
- rilzabrutinibGenzyme Corporation
- sarilumabSanofi-Aventis U.S. LLC
- Thyrotropin AlfaGenzyme Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.